Closed tender

(NU/1257) Clinical Trail Unit or Contracted Research Organisation to Set up and Manage Vision DMD Phase 2b and extension study

Details

Topic
Research and development services and related consultancy services
Published
20 February 2017
Submission
22 March 2017

Tender description

Building on positive preclinical and Phase 1 results funded by government grants and international patient groups and based on FDA and EMA advice, VISION-DMD proposes a Phase 2 registration directed clinical programme aimed at an affordable therapy: Phase 2a will study the safety and tolerability of ascending doses of Vamorolone in ambulant DMD boys; Phase 2b will demonstrate the efficacy and safety of two doses of Vamorolone in young ambulant DMD boys. Keywords: Clinical Trial, Research Manager

Timeline

  1. Completed: Tender published20 February 2017
    Current notice
  2. Completed: Submission date22 March 2017

About the buyer

Newcastle University is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 73000000 · Research and development services and related consultancy services

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

32 similar open tenders

See more open tenders related to (NU/1257) Clinical Trail Unit or Contracted Research Organisation to Set up and Manage Vision DMD Phase 2b and extension study.

Explore all open tenders

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.